PHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Mar 2016

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2016
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2016
The figures have not been audited

Attachments

Pharma Q1 Fin Result.pdf
294.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2016

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2016
31 Mar 2015
31 Mar 2016
31 Mar 2015
$$'000
$$'000
$$'000
$$'000
1 Revenue
559,195
471,904
559,195
471,904
2 Profit/(loss) before tax
26,538
38,612
26,538
38,612
3 Profit/(loss) for the period
18,470
31,926
18,470
31,926
4 Profit/(loss) attributable to ordinary equity holders of the parent
18,379
31,794
18,379
31,794
5 Basic earnings/(loss) per share (Subunit)
7.10
12.28
7.10
12.28
6 Proposed/Declared dividend per share (Subunit)
4.00
7.00
4.00
7.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9930
2.0450

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 13 May 2016
Category Financial Results
Reference Number FRA-11052016-00015